Prokidney to present at the bofa securities health care conference 2023

Winston-salem, n.c., may 04, 2023 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today announced that dr. tim bertram, chief executive officer, will present at the bofa securities health care conference 2023 in las vegas, nv on tuesday, may 9, 2023, at 4:20 pm pdt (7:20 pm edt).
PROK Ratings Summary
PROK Quant Ranking